< Back to Team

Chris S. Hassan

President and Chief Executive Officer

Chris Hassan created Symetria Health®, the country’s first comprehensive evidence-based opioid addiction treatment program, to deliver data-validated outcomes that outperform other treatments currently available. He is a senior Healthcare executive with over 25 years of experience in the field of addiction treatment.

Prior to coming to Symetria Health®, Chris co-founded Reckitt Benckiser Pharmaceuticals creating the office-based treatment model for opioid dependence and launching Suboxone®. Subsequently, he served as Chief Executive Officer of Colonial Management Group - the largest chain of opioid addiction treatment centers in the US. He also developed and patented a number of new opioid product combinations focused on preventing diversion and inadvertent benzodiazepine overdose in patients.

Get Help Fighting Opioid Addiction Today

If you’ve been worried about a loved one, or if you’re concerned about the way you use your pain medication, we urge you to contact us as soon as possible for help. To take the first step, contact us online or call  right away.

Results

Symetria Recovery’s success rate is 4x greater than the industry average.

After six months, 9 in 10 patients are having success in treatment.

Only 13% of patients returned to use of addictive substances at one year follow up.

99% of patients did not require admission to a higher level of care than we offer onsite.

The proof is in the numbers

See More Results